iStent Inject New Enrollment Post-Approval Study

NAActive, not recruitingINTERVENTIONAL

Enrollment

358

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions

Glaucoma, Open-AngleGlaucoma

Interventions

DEVICE

iStent Inject Implantation

Subjects will be implanted with the iStent Injection Micro-Bypass device

Trial Locations (3)

Glaucoma Associates of Texas, Dallas

Eye Doctors of Arizona, PLLC, Phoenix

Wolstan and Goldberg Eye Associates, Torrance